Statistics
Publications
1
Citations
11
H-Index
1
Active since
2013
Affiliations
D Hrenuik is an author at Merck & Co., Inc., Rahway, NJ, USA (United States).
Publications per year
2013–2013
1
1
Odanacatib does not influence the single dose pharmacokinetics and pharmacodynamics of warfarin.
SA Stoch, Rose Witter, D Hrenuik et al. · PubMed · 2013 · 11 citations
Rows per page
1–1 of 1